Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign ...

The conference represents a unique collaboration between the Prader-Willi Syndrome Association | USA (PWSA | USA), the Foundation for Prader-Willi Research (FPWR), and the International Prader-Willi ...

Company reports rapid commercial growth, reaches customers in 19 countries, and prepares for next phase of innovation with ...

The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...

The Potters are reportedly interested in signing midfielder Habib Keita from French Ligue 2 side Clermont Foot.

In February 2025, BioRestorative Therapies announced that the FDA cleared its Investigational New Drug (IND) application for ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Sale prices for the vouchers – which slash FDA review times for a drug – have increased in the past year as biotech funding ...

Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...

Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.